Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps
Efflux, a natural process in all cells, is a key resistance mechanism for multidrug-resistant bacteria. Chemical inhibition of efflux pumps has been a promising approach for antimicrobial chemotherapy. Over 50 efflux inhibitors target these systems, but none have been clinically used due to formulation, toxicity, and pharmacokinetic issues. Recent computational tools and molecular docking models offer hope for further research on efflux inhibitors, potentially serving as a platform for new bacterial efflux inhibitors.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!